My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

5.170 -0.320 (-5.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ATAI Life Sciences N.V. - Common Shares

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
28 29 Next >
Psychedelic Stock Gainers And Losers From December 13, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 12, 2022
 
Via Benzinga
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 9, 2022
 
Via Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 7, 2022
 
Via Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
 
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 2, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 1, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022
 
Via Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
3 Big Trends Shaking Up Psychedelic Stocks
Major positive shifts are happening, but the field faces new headwinds too. 
Via The Motley Fool
atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer
From atai Life Sciences
Via GlobeNewswire
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 25, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
 
Via Benzinga
Tesla, Deere And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
(Part three of a four-part series) Have a look at previous stories: 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
 
Via Benzinga
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date. 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
 
Via Benzinga
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter... 
Via Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
 
Via Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment
From atai Life Sciences
Via GlobeNewswire
Psychedelic Stock Gainers And Losers From November 16, 2022
 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.